Canaccord Genuity Assumes Beauty Health at Buy, Announces Price Target of $10
Portfolio Pulse from richadhand@benzinga.com
Canaccord Genuity analyst Kyle Rose has assumed Beauty Health (NASDAQ:SKIN) with a Buy rating and set a price target of $10.
August 25, 2023 | 9:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity has given Beauty Health a Buy rating with a price target of $10.
The Buy rating and price target set by Canaccord Genuity is a positive signal for Beauty Health. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100